カテゴリ： FactMR, 世界, 部品/材料

ゲムシタビンHCl（塩酸塩）のグローバル市場2023～2033：ブランド医薬品、ジェネリック医薬品

■ 英語タイトル：Gemcitabine HCl Market By Type (Branded, Generic), By Application (Pancreatic Cancer, Breast Cancer, Ovarian Cancer, Non-Small-Cell Lung Carcinoma (NSCLC)), By End User (Hospitals, Cancer Centers), and Region - Global Market Insights 2023 to 2033

調査会社FactMR社が発行したリサーチレポート（データ管理コード：FACT23MA042）■ 発行会社/調査会社：FactMR
■ 商品コード：FACT23MA042
■ 発行日：2023年4月14日
■ 調査対象地域：グローバル
■ 産業分野：化学
■ ページ数：約170
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）USD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
Global Sie License（同一拠点内共有可）USD8,500 ⇒換算￥1,292,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※FactMR社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ゲムシタビンHCl（塩酸塩）のグローバル市場2023～2033：ブランド医薬品、ジェネリック医薬品]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Fact.MR社の本市場調査レポートは、予測期間（2023年〜2033年）における世界のゲムシタビンHCl（塩酸塩）市場について、市場状況や動向を推測した資料です。本レポートは、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場動向、主要インサイト、種類別（ブランド医薬品、ジェネリック医薬品）分析、用途別（膵臓がん、乳がん、卵巣がん、非小細胞肺がん（NSCLC）、その他）分析、エンドユーザー別（病院、がんセンター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目を掲載しています。また、本書内には、Teva Pharmaceutical Industries Ltd.、Accord-UK Ltd、Pfizer Incなど、主要企業情報を含んでいます。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・市場動向
・主要インサイト
・世界のゲムシタビンHCl（塩酸塩）市場規模：種類別
- ブランド医薬品の市場規模
- ジェネリック医薬品の市場規模
・世界のゲムシタビンHCl（塩酸塩）市場規模：用途別
- 膵臓がんにおける市場規模
- 乳がんにおける市場規模
- 卵巣がんにおける市場規模
- 非小細胞肺がん（NSCLC）における市場規模
- その他用途における市場規模
・世界のゲムシタビンHCl（塩酸塩）市場規模：エンドユーザー別
- 病院における市場規模
- がんセンターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界のゲムシタビンHCl（塩酸塩）市場規模：地域別
- 北米のゲムシタビンHCl（塩酸塩）市場規模
- ヨーロッパのゲムシタビンHCl（塩酸塩）市場規模
- アジア太平洋のゲムシタビンHCl（塩酸塩）市場規模
- 中南米のゲムシタビンHCl（塩酸塩）市場規模
- 中東・アフリカのゲムシタビンHCl（塩酸塩）市場規模
・競争状況

本書には、各参入企業の製品ポートフォリオ、主要戦略及び包括的なSWOT分析などの要素を含む企業情報が含まれています。企業のプレゼンスは、全著名プレーヤーについてマッピングされ、マトリックスにより提供されます。したがって、レポートの読者に実用的洞察を提示し、熟考して市場状況を提供し、ゲムシタビンHCl（塩酸塩）における競争レベルを予想するのに活用できます。

Gemcitabine HCl Market – Scope of Report

A recent study by Fact.MR on the Gemcitabine HCl market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering Gemcitabine HCl.
The study also provides the dynamics responsible for influencing the future status of the Gemcitabine HCl market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.
A list of prominent companies operating in the Gemcitabine HCl market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of Gemcitabine HCl across the globe.
A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of Gemcitabine HCl during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).
Estimates at global and regional levels for Gemcitabine HCl are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.
Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global Gemcitabine HCl market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the Gemcitabine HCl market during the forecast period.
Country-specific valuation on demand for Gemcitabine HCl has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of XYZ, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering Gemcitabine HCl has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the Gemcitabine HCl domain.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Market Analysis, by Region, 2023 and 2033

    3.2. Global Market: Market Snapshot

4. Market Overview

    4.1. Global Market Overview

    4.2. Global Market Key Industry Developments

5. Market Dynamics

    5.1. Drivers and Restraints Snapshot Analysis

    5.2. Drivers

    5.3. Restraints

    5.4. Opportunities

6. Key Insights

    6.1. Disease Prevalence & Incidence Rate globally with key countries

    6.2. Regulatory Scenario by Region/globally

    6.3. Pipeline Analysis

    6.4. Key Mergers & Acquisitions

    6.5. Pricing Analysis of Finished products

    6.6. Overview of Manufacturers

    6.7. Consumption of (Volume) per Region (2022)

    6.8. Prices by Key Manufacturers(USD/kg)

    6.9. Overview of Manufacturers

7. Global Market Analysis, by Type

    7.1. Introduction

    7.2. Key Insights

    7.3. Global Market Size and Forecast, by Type

        7.3.1. Branded

        7.3.2. Generic

    7.4. Global Market Analysis, by Type

    7.5. Global Market Attractiveness Analysis, by Type

8. Global Market Analysis, by Application

    8.1. Introduction

    8.2. Key Insights

    8.3. Global Market Size and Forecast, by Application

        8.3.1. Pancreatic Cancer

        8.3.2. Breast Cancer

        8.3.3. Ovarian Cancer

        8.3.4. Non-small-cell lung carcinoma (NSCLC)

        8.3.5. Other

    8.4. Global Market Analysis, by Application

    8.5. Global Market Attractiveness Analysis, by Application

9. Global Market Analysis, by End-user

    9.1. Introduction

    9.2. Key Insights

    9.3. Global Market Application and Forecast, by End-user

        9.3.1. Hospitals

        9.3.2. Cancer Centers

        9.3.3. Others

    9.4. Global Market Analysis, by End-user

    9.5. Global Market Attractiveness Analysis, by End-user

10. Global Market Analysis, by Region

    10.1. Introduction

    10.2. Key Insights

    10.3. Global Market Size and Forecast , by Region, 2018-2033

        10.3.1. North America

        10.3.2. Europe

        10.3.3. Asia Pacific

        10.3.4. Latin America

        10.3.5. Middle East & Africa

    10.4. Global Market Analysis, by Region

    10.5. Global Market Attractiveness Analysis, by Region

11. North America Market Analysis

    11.1. North America Market Key Findings

    11.2. North America Market Overview

    11.3. North America Market Size and Forecast, by Type

        11.3.1. Branded

        11.3.2. Generic

    11.4. North America Market Size and Forecast, by Application

        11.4.1. Pancreatic Cancer

        11.4.2. Breast Cancer

        11.4.3. Ovarian Cancer

        11.4.4. Non-small-cell lung carcinoma (NSCLC)

        11.4.5. Other

    11.5. North America Market Size and Forecast, by End-user

        11.5.1. Hospitals

        11.5.2. Cancer Centers

        11.5.3. Others

    11.6. North America Market Forecast, by Country

        11.6.1. U.S.

        11.6.2. Canada

    11.7. North America Market Attractiveness Analysis

        11.7.1. By Type

        11.7.2. By Application

        11.7.3. By End-user

        11.7.4. By Country

12. Europe Market Analysis

    12.1. Europe Market Key Findings

    12.2. Europe Market Overview

    12.3. Europe Market Size and Forecast, by Type

        12.3.1. Branded

        12.3.2. Generic

    12.4. Europe Market Size and Forecast, by Application

        12.4.1. Pancreatic Cancer

        12.4.2. Breast Cancer

        12.4.3. Ovarian Cancer

        12.4.4. Non-small-cell lung carcinoma (NSCLC)

        12.4.5. Other

    12.5. Europe Market Size and Forecast, by End-user

        12.5.1. Hospitals

        12.5.2. Cancer Centers

        12.5.3. Others

    12.6. Europe Market Forecast, by Country

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Europe Market Attractiveness Analysis

        12.7.1. By Type

        12.7.2. By Application

        12.7.3. By End-user

        12.7.4. By Country

13. Asia Pacific Market Analysis

    13.1. Asia Pacific Market Key Findings

    13.2. Asia Pacific Market Overview

    13.3. Asia Pacific Cytometry Market Size and Forecast, by Type

        13.3.1. Branded

        13.3.2. Generic

    13.4. Asia Pacific Market Size and Forecast, by Application

        13.4.1. Pancreatic Cancer

        13.4.2. Breast Cancer

        13.4.3. Ovarian Cancer

        13.4.4. Non-small-cell lung carcinoma (NSCLC)

        13.4.5. Other

    13.5. Asia Pacific Market Size and Forecast, by End-user

        13.5.1. Hospitals

        13.5.2. Cancer Centers

        13.5.3. Others

    13.6. Asia Pacific Market Forecast, by Country

        13.6.1. China

        13.6.2. India

        13.6.3. Japan

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Asia Pacific Market Attractiveness Analysis

        13.7.1. By Type

        13.7.2. By Application

        13.7.3. By End-user

        13.7.4. By Country

14. Latin America Market Analysis

    14.1. Latin America Market Key Findings

    14.2. Latin America Market Overview

    14.3. Latin America Cytometry Market Size and Forecast, by Type

        14.3.1. Branded

        14.3.2. Generic

    14.4. Latin America Market Size and Forecast, by Application

        14.4.1. Pancreatic Cancer

        14.4.2. Breast Cancer

        14.4.3. Ovarian Cancer

        14.4.4. Non-small-cell lung carcinoma (NSCLC)

        14.4.5. Other

    14.5. Latin America Market Size and Forecast, by End-user

        14.5.1. Hospitals

        14.5.2. Cancer Centers

        14.5.3. Others

    14.6. Latin America Market Forecast, by Country

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Latin America Market Attractiveness Analysis

        14.7.1. By Type

        14.7.2. By Application

        14.7.3. By End-user

        14.7.4. By Country

15. Middle East & Africa Market Analysis

    15.1. Middle East & Africa Market Key Findings

    15.2. Middle East & Africa Market Overview

    15.3. Middle East & Africa Cytometry Market Size and Forecast, by Type

        15.3.1. Branded

        15.3.2. Generic

    15.4. Middle East & Africa Market Size and Forecast, by Application

        15.4.1. Pancreatic Cancer

        15.4.2. Breast Cancer

        15.4.3. Ovarian Cancer

        15.4.4. Non-small-cell lung carcinoma (NSCLC)

        15.4.5. Other

    15.5. Middle East & Africa Market Size and Forecast, by End-user

        15.5.1. Hospitals

        15.5.2. Cancer Centers

        15.5.3. Others

    15.6. Middle East Market Forecast, by Country

        15.6.1. South Africa

        15.6.2. Saudi Arabia

        15.6.3. U.A.E.

        15.6.4. Rest of Middle East & Africa

    15.7. Middle East Market Attractiveness Analysis

        15.7.1. By Type

        15.7.2. By Application

        15.7.3. By End-user

        15.7.4. By Country

16. Competition Landscape

    16.1. Global Market Share Analysis, by Company (2022)

    16.2. Company Profiles

        16.2.1. Eli Lilly and Company

            16.2.1.1. Overview (HQ, Employee Strength, Business Segments)

            16.2.1.2. Financials

            16.2.1.3. Recent Developments

            16.2.1.4. Strategy

        16.2.2. Teva Pharmaceutical Industries Ltd.

            16.2.2.1. Overview (HQ, Employee Strength, Business Segments)

            16.2.2.2. Financials

            16.2.2.3. Recent Developments

            16.2.2.4. Strategy

        16.2.3. Accord-UK Ltd

            16.2.3.1. Overview (HQ, Employee Strength, Business Segments)

            16.2.3.2. Financials

            16.2.3.3. Recent Developments

            16.2.3.4. Strategy

        16.2.4. Pfizer Inc

            16.2.4.1. Overview (HQ, Employee Strength, Business Segments)

            16.2.4.2. Financials

            16.2.4.3. Recent Developments

            16.2.4.4. Strategy

        16.2.5. Mylan N.V.

            16.2.5.1. Overview (HQ, Employee Strength, Business Segments)

            16.2.5.2. Financials

            16.2.5.3. Recent Developments

            16.2.5.4. Strategy

        16.2.6. Sun Pharmaceutical Industries Ltd

            16.2.6.1. Overview (HQ, Employee Strength, Business Segments)

            16.2.6.2. Financials

            16.2.6.3. Recent Developments

            16.2.6.4. Strategy

        16.2.7. Fresenius Kabi AG

            16.2.7.1. Overview (HQ, Employee Strength, Business Segments)

            16.2.7.2. Financials

            16.2.7.3. Recent Developments

            16.2.7.4. Strategy

        16.2.8. Dr. Reddy’s Laboratories Ltd.

            16.2.8.1. Overview (HQ, Employee Strength, Business Segments)

            16.2.8.2. Financials

            16.2.8.3. Recent Developments

            16.2.8.4. Strategy

        16.2.9. Ingenus Pharmaceuticals

            16.2.9.1. Overview (HQ, Employee Strength, Business Segments)

            16.2.9.2. Financials

            16.2.9.3. Recent Developments

            16.2.9.4. Strategy

Table 01: Global Market Size (US$ Mn) Analysis, by Type, 2018-2022

Table 02: Global Market Size (US$ Mn) Forecast, by Type, 2023-2033

Table 03: Global Market Size (US$ Mn) Analysis, by Branded, 2018-2022

Table 04: Global Market Size (US$ Mn) Forecast, by Branded, 2023-2033

Table 05: Global Market Size (US$ Mn) Analysis, by Generic, 2018-2022

Table 06: Global Market Size (US$ Mn) Forecast, by Generic, 2023-2033

Table 07: Global Market Size (US$ Mn) Analysis, by Application, 2018-2022

Table 08: Global Market Size (US$ Mn) Forecast, by Application, 2023-2033

Table 09: Global Market Size (US$ Mn) Analysis, by Pancreatic Cancer, 2018-2022

Table 10: Global Market Size (US$ Mn) Forecast, by Pancreatic Cancer, 2023-2033

Table 11: Global Market Size (US$ Mn) Analysis, by Breast Cancer, 2018-2022

Table 12: Global Market Size (US$ Mn) Forecast, by Breast Cancer, 2023-2033

Table 13: Global Market Size (US$ Mn) Analysis, by Ovarian Cancer, 2018-2022

Table 14: Global Market Size (US$ Mn) Forecast, by Ovarian Cancer, 2023-2033

Table 15: Global Market Size (US$ Mn) Analysis, by Non-small-cell lung carcinoma (NSCLC), 2018-2022

Table 16: Global Market Size (US$ Mn) Forecast, by Non-small-cell lung carcinoma (NSCLC), 2023-2033

Table 17: Global Market Size (US$ Mn) Analysis, by Others, 2018-2022

Table 18: Global Market Size (US$ Mn) Forecast, by Others, 2023-2033

Table 19: Global Market Size (US$ Mn) Analysis, by End-user, 2018-2022

Table 20: Global Market Size (US$ Mn) Forecast, by End-user, 2023-2033

Table 21: Global Market Size (US$ Mn) Analysis, by Hospitals, 2018-2022

Table 22: Global Market Size (US$ Mn) Forecast, by Hospitals, 2023-2033

Table 23: Global Market Size (US$ Mn) Analysis, by Cancer Center, 2018-2022

Table 24: Global Market Size (US$ Mn) Forecast, by Cancer Center, 2023-2033

Table 25: Global Market Size (US$ Mn) Analysis, by Others, 2018-2022

Table 26: Global Market Size (US$ Mn) Forecast, by Others, 2023-2033

Table 27: Global Market Size (US$ Mn) Analysis, by Region, 2018-2022

Table 28: Global Market Size (US$ Mn) Forecast, by Region, 2023-2033

Table 29: North America Market Size (US$ Mn) Analysis, by Type, 2018-2022

Table 30: North America Market Size (US$ Mn) Forecast, by Type, 2023-2033

Table 31: North America Market Size (US$ Mn) Analysis, by Application, 2018-2022

Table 32: North America Market Size (US$ Mn) Forecast, by Application, 2023-2033

Table 33: North America Market Size (US$ Mn) Analysis, by End-user, 2018-2022

Table 34: North America Market Size (US$ Mn) Forecast, by End-user, 2023-2033

Table 35: North America Market Size (US$ Mn) Analysis, by Country, 2018-2022

Table 36: North America Market Size (US$ Mn) Forecast, by Country, 2023-2033

Table 37: Europe Market Size (US$ Mn) Analysis, by Type, 2018-2022

Table 38: Europe Market Size (US$ Mn) Forecast, by Type, 2023-2033

Table 39: Europe Market Size (US$ Mn) Analysis, by Application, 2018-2022

Table 40: Europe Market Size (US$ Mn) Forecast, by Application, 2023-2033

Table 41: Europe Market Size (US$ Mn) Analysis, by End-user, 2018-2022

Table 42: Europe Market Size (US$ Mn) Forecast, by End-user, 2023-2033

Table 43: Europe Market Size (US$ Mn) Analysis, by Country, 2018-2022

Table 44: Europe Market Size (US$ Mn) Forecast, by Country, 2023-2033

Table 45: Asia Pacific Market Size (US$ Mn) Analysis, by Type, 2018-2022

Table 46: Asia Pacific Market Size (US$ Mn) Forecast, by Type, 2023-2033

Table 47: Asia Pacific Market Size (US$ Mn) Analysis, by Application, 2018-2022

Table 48: Asia Pacific Market Size (US$ Mn) Forecast, by Application, 2023-2033

Table 49: Asia Pacific Market Size (US$ Mn) Analysis, by End-user, 2018-2022

Table 50: Asia Pacific Market Size (US$ Mn) Forecast, by End-user, 2023-2033

Table 51: Asia Pacific Market Size (US$ Mn) Analysis, by Country, 2018-2022

Table 52: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2023-2033

Table 53: Latin America Market Size (US$ Mn) Analysis, by Type, 2018-2022

Table 54: Latin America Market Size (US$ Mn) Forecast, by Type, 2023-2033

Table 55: Latin America Market Size (US$ Mn) Analysis, by Application, 2018-2022

Table 56: Latin America Market Size (US$ Mn) Forecast, by Application, 2023-2033

Table 57: Latin America Market Size (US$ Mn) Analysis, by End-user, 2018-2022

Table 58: Latin America Market Size (US$ Mn) Forecast, by End-user, 2023-2033

Table 59: Latin America Market Size (US$ Mn) Analysis, by Country, 2018-2022

Table 60: Latin America Market Size (US$ Mn) Forecast, by Country, 2023-2033

Table 61: MEA Market Size (US$ Mn) Analysis, by Type, 2018-2022

Table 62: MEA Market Size (US$ Mn) Forecast, by Type, 2023-2033

Table 63: MEA Market Size (US$ Mn) Analysis, by Application, 2018-2022

Table 64: MEA Market Size (US$ Mn) Forecast, by Application, 2023-2033

Table 65: MEA Market Size (US$ Mn) Analysis, by End-user, 2018-2022

Table 66: MEA Market Size (US$ Mn) Forecast, by End-user, 2023-2033

Table 67: MEA Market Size (US$ Mn) Analysis, by Country, 2018-2022

Table 68: MEA Market Size (US$ Mn) Forecast, by Country, 2023-2033

Table 69: U.S. Market Size (US$ Mn), 2023-2033

Table 70: Canada Market Size (US$ Mn), 2023-2033

Table 71: Brazil Market Size (US$ Mn), 2023-2033

Table 72: Mexico Market Size (US$ Mn), 2023-2033

Table 73: Argentina Market Size (US$ Mn), 2023-2033

Table 74: Germany Market Size (US$ Mn), 2023-2033

Table 75: France Market Size (US$ Mn), 2023-2033

Table 76: Italy Market Size (US$ Mn), 2023-2033

Table 77: Spain Market Size (US$ Mn), 2023-2033

Table 78: U.K. Market Size (US$ Mn), 2023-2033

Table 79: Benelux Market Size (US$ Mn), 2023-2033

Table 80: Russia Market Size (US$ Mn), 2023-2033

Table 81: China Market Size (US$ Mn), 2023-2033

Table 82: Japan Market Size (US$ Mn), 2023-2033

Table 83: South Korea Market Size (US$ Mn), 2023-2033

Table 84: India Market Size (US$ Mn), 2023-2033

Table 85: Thailand Market Size (US$ Mn), 2023-2033

Table 86: Indonesia Market Size (US$ Mn), 2023-2033

Table 87: Malaysia Market Size (US$ Mn), 2023-2033

Table 88: Australia & New Zealand Market Size (US$ Mn), 2023-2033

Table 89: GCC Countries Market Size (US$ Mn), 2023-2033

Table 90: Egypt Market Size (US$ Mn), 2023-2033

Table 91: South Africa Market Size (US$ Mn), 2023-2033

Table 92: Turkey Market Size (US$ Mn), 2023-2033

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • レミケード（インフリキシマブ） 薬の世界市場2022：ブランド医薬品、ジェネリック医薬品
  • 医薬品のグローバル市場展望 2023年-2029年：ブランド医薬品、ジェネリック医薬品
  • OTCドライアイ用点眼薬のグローバル市場（2023～2030）：ブランド医薬品、ジェネリック医薬品
  • コンピュータ支援検出（CAD）のグローバル市場2023～2033：がん、心血管＆神経系疾患
  • ポリビニルアルコール（PVA）のグローバル市場2023～2033：完全加水分解、部分的加水分解、亜部分的加水分解、低発泡
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(FACT23MA042 )"ゲムシタビンHCl（塩酸塩）のグローバル市場2023～2033：ブランド医薬品、ジェネリック医薬品" (英文：Gemcitabine HCl Market By Type (Branded, Generic), By Application (Pancreatic Cancer, Breast Cancer, Ovarian Cancer, Non-Small-Cell Lung Carcinoma (NSCLC)), By End User (Hospitals, Cancer Centers), and Region - Global Market Insights 2023 to 2033)はFactMR社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。